Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 780

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 780
---
 service, by 4:00 p.m. on a Business Day, addressee’s day and time, on the date of delivery, and otherwise on the first Business Day after such delivery; (b) if by email, on the date that transmission is confirmed electronically, if by 4:00 p.m. on a Business Day, addressee’s day and time, and otherwise on the first Business Day after the date of such confirmation; or (c) five days after mailing by certified or registered mail, return receipt requested. Notices shall be addressed to the respective parties as follows (excluding telephone numbers, which are for convenience

<div align='center'>G-3</div>

TABLE OF CONTENTS

only), or to such other address as a party shall specify to the others in accordance with these notice provisions:

(a) If to ParentCo, to:

Liminatus Pharma, LLC 
 Address: 6 Centerpointe Dr. #625 
 La Palma, CA 90625 
 Attention: Chris Kim 
 E-mail: chris@liminatuspharma.com

with a copy to (which shall not constitute notice):

Loeb & Loeb LLP 
 Address: 345 Park Avenue 
 Attention: Mitchell Nussbaum 
 E-mail: mnussbaum@loeb.com

(b) If to the Holder, to the address set forth on the Holder’s signature page hereto, with a copy, which shall not constitute notice, to:

Email:

(c) If to Sponsor, to:

Iris Acquisition Holdings LLC 
 c/o Iris Acquisition Corp 
 3rd Floor Zephyr House 
 122 Mary Street, George Town 
 PO Box 10085 
 Grand Cayman KY1-1001, Cayman Islands 
 Attention: Sumit Mehta 
 E-mail: sumit.mehta@arrcap.com

with a copy to (which shall not constitute notice):

Holland & Knight LLP 
 One Arts Plaza 
 1722 Routh Street 
 Suite 1500 
 Dallas, TX 75201 
 Attention: Chauncey M. Lane 
 E-mail: Chauncey.Lane@hklaw.com

or to such other address(es) as any party may have furnished to the others in writing in accordance herewith.

7. Enumeration and Headings. The enumeration and headings contained in this Agreement are for convenience of reference only and shall not control or affect the meaning or construction of any of the provisions of this Agreement.

8. Counterparts. This Agreement may be executed